{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T09:07:49Z","timestamp":1770541669398,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Granulocyte colony-stimulating factor (G-CSF) is increasingly used to prevent chemotherapy-associated febrile neutropenia. Generally, aortitis is not considered a side effect of G-CSF and is thought to be extremely rare. Aortitis is an inflammation of the aorta and occurs mainly in connective tissue diseases (Takayasu arteritis, giant cell arteritis, etc.) and infectious diseases (bacterial endocarditis, syphilis, etc.). We report herein a rare case of G-CSF associated with aortitis in a woman with breast cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Here, we present a case involving a 63-year-old woman with luminal type stage IIa breast cancer. The patient\u2019s treatment was initiated with docetaxel and cyclophosphamide, with pegfilgrastim (PEG-G) as support. After PEG-G administration on day 3, the patient developed an intermittent fever of up to 39.4\u00a0\u00b0C on day 10 and visited our outpatient clinic on day 13 with persistent high fever. Laboratory tests revealed a high neutrophil count (14,000\/\u03bcL) and a high C-reactive protein (CRP) level (42.8\u00a0mg\/dL) without any other abnormalities. Contrast-enhanced computed tomography scanning revealed soft tissue thickening with weak enhancement around the wall of the thoraco-abdominal aorta, aortic arch and left subclavian artery. The patient did not respond to antimicrobial agents. On the basis of these observations, the patient was diagnosed with PEG-G-induced aortitis, and her condition rapidly improved without corticosteroids.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Clinicians should be aware of aortitis as a potential complication in patients undergoing G-CSF chemotherapy. In cases with persistent high fever after PEG-G administration, and in the absence of infection, aortitis should be suspected.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40792-022-01514-6","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T08:02:28Z","timestamp":1660809748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Granulocyte colony-stimulating factor-associated aortitis in a woman with breast cancer: a case report"],"prefix":"10.1186","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8906-7003","authenticated-orcid":false,"given":"Nana","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Wanifuchi-Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoka","family":"Hisada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Uemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"Terada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaka","family":"Isogai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muneyuki","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Mashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,18]]},"reference":[{"key":"1514_CR1","first-page":"CD007913","volume":"10","author":"P Renner","year":"2012","unstructured":"Renner P, Milazzo S, Liu JP, Zwahlen M, Birkmann J, Horneber M. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients. Cochrane Database Syst Rev. 2012;10:CD007913.","journal-title":"Cochrane Database Syst Rev"},{"key":"1514_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cyto.2019.02.013","volume":"119","author":"Y Oshima","year":"2019","unstructured":"Oshima Y, Takahashi S, Tani K, Tojo A. Granulocyte colony-stimulating factor-associated aortitis in the Japanese adverse drug event report database. Cytokine. 2019;119:47\u201351.","journal-title":"Cytokine"},{"key":"1514_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11926-002-0018-9","volume":"4","author":"R Cuchacovich","year":"2002","unstructured":"Cuchacovich R. Immunopathogenesis of vasculitis. Curr Rheumatol Rep. 2002;4:9\u201317.","journal-title":"Curr Rheumatol Rep"},{"key":"1514_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S1074-7613(02)00424-7","volume":"17","author":"CL Semerad","year":"2002","unstructured":"Semerad CL, Liu F, Gregory AD, Stumpf K, Link DC. G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood. Immunity. 2002;17:413\u201323.","journal-title":"Immunity"},{"key":"1514_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2015.11.084","volume":"80","author":"E Bossone","year":"2016","unstructured":"Bossone E, Pluchinotta FR, Andreas M, Blanc P, Citro R, Limongelli G, et al. Aortitis. Vasc Pharmacol. 2016;80:1\u201310.","journal-title":"Vasc Pharmacol"},{"key":"1514_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytaa503","author":"M Harada","year":"2020","unstructured":"Harada M, Motoki H, Sakai T, Kuwahara K. Granulocyte colony stimulating factor-associated aortitis evaluated via multiple imaging modalities including vascular echography: a case report. Eur Soc Cardiol. 2020. https:\/\/doi.org\/10.1093\/ehjcr\/ytaa503.","journal-title":"Eur Soc Cardiol"},{"key":"1514_CR7","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.2169\/internalmedicine.4331-19","volume":"59","author":"T Shirai","year":"2020","unstructured":"Shirai T, Komatsu H, Sato H, Fujii H, Ishii T, Harigae H. Migratory aortitis associated with granulocyte-colony-stimulating factor. Intern Med. 2020;59:1559\u201363.","journal-title":"Intern Med"},{"key":"1514_CR8","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1186\/s12885-019-6403-9","volume":"19","author":"H Hoshina","year":"2019","unstructured":"Hoshina H, Takei H. Granulocyte-colony stimulating factor-associated aortitis in a woman with advanced breast cancer: a case report and review of the literature. BMC Cancer. 2019;19:1217. https:\/\/doi.org\/10.1186\/s12885-019-6403-9.","journal-title":"BMC Cancer"},{"key":"1514_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s40792-021-01282-9","volume":"7","author":"H Jimbo","year":"2021","unstructured":"Jimbo H, et al. Drug-induced aortitis of the subclavian artery caused by pegfilgrastim: a case report. Surg Case Rep. 2021;7:197.","journal-title":"Surg Case Rep"},{"key":"1514_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40792-021-01111-z","volume":"7","author":"Y Koyama","year":"2021","unstructured":"Koyama Y, et al. Successful treatment of G-CSF-related aortitis with prednisolone during preoperative chemotherapy for breast cancer: a case report. Surg Case Rep. 2021;7:23.","journal-title":"Surg Case Rep"},{"key":"1514_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s13691-018-00357-z","volume":"8","author":"Y Kinjo","year":"2019","unstructured":"Kinjo Y, et al. Acute arteritis after G-CSF administration. Int Cancer Conf J. 2019;8:77\u201380.","journal-title":"Int Cancer Conf J."},{"issue":"12","key":"1514_CR12","first-page":"1771","volume":"45","author":"T Chino","year":"2018","unstructured":"Chino T, et al. A Case of arteritis that developed after pegfilgrastim administration during chemotherapy for breast cancer. Jpn J Cancer Chemother. 2018;45(12):1771\u20134.","journal-title":"Jpn J Cancer Chemother"},{"issue":"6","key":"1514_CR13","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.autrev.2018.12.011","volume":"18","author":"I Parodis","year":"2019","unstructured":"Parodis I, et al. G-CSF-induced aortitis: two cases and review of the literature. Autoimmun Rev. 2019;18(6):615\u201320.","journal-title":"Autoimmun Rev"},{"key":"1514_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/24725625.2019.1629570","volume":"4","author":"T Mukai","year":"2020","unstructured":"Mukai T, Kubo S, Morita Y, Yamamoto M, Ikeda M. Aortitis which developed after the administration of granulocyte-colony stimulating factor. Modern Rheumatol Case Rep. 2020;4:74\u20138.","journal-title":"Modern Rheumatol Case Rep"},{"key":"1514_CR15","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1200\/JCO.2003.09.081","volume":"21","author":"ML Citron","year":"2003","unstructured":"Citron ML, et al. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of intergroup trial C9741\/ cancer and leukemia group B trial 9741. J Clin Oncol. 2003;21:1431\u20139.","journal-title":"J Clin Oncol"},{"key":"1514_CR16","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/sj.bjc.6603085","volume":"94","author":"S Kummel","year":"2006","unstructured":"Kummel S, et al. Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer. Br J Cancer. 2006;94:1237\u201344.","journal-title":"Br J Cancer"},{"key":"1514_CR17","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1200\/JCO.2005.09.102","volume":"23","author":"CL Vogel","year":"2005","unstructured":"Vogel CL, et al. First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study. J Clin Oncol. 2005;23:1178\u201384.","journal-title":"J Clin Oncol"},{"key":"1514_CR18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1200\/JCO.2002.20.3.727","volume":"20","author":"FA Holmes","year":"2002","unstructured":"Holmes FA, et al. Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III\/IV breast cancer. J Clin Oncol. 2002;20:727\u201331.","journal-title":"J Clin Oncol"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-022-01514-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40792-022-01514-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-022-01514-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T08:02:38Z","timestamp":1660809758000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-022-01514-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,18]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1514"],"URL":"https:\/\/doi.org\/10.1186\/s40792-022-01514-6","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,18]]},"assertion":[{"value":"25 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient gave written informed consent for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}